Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.
Agricultural companies are thinking about how to get consumers comfortable with gene-edited crops, the Wall Street Journal says.
The system uses synthetic probes that bind to molecules of interest and then pass through solid-state nanopores, enabling detection of the target molecules.
The agricultural company said it will use the licensed technology to develop improved and sustainable crops.
The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.
Under the terms of the deals, Illumina and Monsanto will have access to NRGene's genome assembly and analysis technologies for ag-bio research projects.
CRISPR/Cpf1 can serve as an alternative or even complementary genome editing technology to CRISPR/Cas9, which Monsanto has also licensed from the Broad.
The technology is based on engineered zinc finger DNA-binding proteins, which bind to specific functional domains to create transcription factors capable of activating or repressing target genes.
The ag-bio giant has landed a worldwide, non-exclusive licensing deal for agricultural applications of the genome-editing technology.
The partners will use their respective genome databases, bioinformatics tools, and other resources to identify new proteins for pest control.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.